Search research articles
Contact Us
Filters
Showing results (111-120 of 250) with videos related to
Page
of 25
Sort By:
Antimicrobial Agents and Chemotherapy
|
January 24, 2019
APX001 Pharmacokinetic/Pharmacodynamic Target Determination against <i>Aspergillus fumigatus</i> in an <i>In Vivo</i> Model of Invasive Pulmonary Aspergillosis
Miao Zhao, Alexander J Lepak, Karen Marchillo, et al.
Chemotherapy
|
April 18, 2001
Pharmacokinetics of high-dose meropenem in adult cystic fibrosis patients
K Q Bui, P G Ambrose, D P Nicolau, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 21, 2024
Piperacillin/Tazobactam Susceptibility Test Interpretive Criteria for Enterobacterales: Recommendations From the United States Committee on Antimicrobial Susceptibility Testing
Thomas P Lodise, Sujata M Bhavnani, Paul G Ambrose, et al.
The Journal of Infectious Diseases
|
December 28, 2006
Isoniazid's bactericidal activity ceases because of the emergence of resistance, not depletion of Mycobacterium tuberculosis in the log phase of growth
Tawanda Gumbo, Arnold Louie, Weiguo Liu, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society
|
May 17, 2022
An objective assessment for bone drilling: A pilot study on vertical drilling
Aman Nigam, Ronak R Mohanty, James F Kellam, et al.
Diagnostic Microbiology and Infectious Disease
|
June 28, 2008
Pharmacokinetics-pharmacodynamics of quinolones against Streptococcus pneumoniae in patients with community-acquired pneumonia
Sujata M Bhavnani, Alan Forrest, Jeffrey P Hammel, et al.
Archives of Internal Medicine
|
October 24, 2002
Undertreatment of osteoporosis in men with hip fracture
Gary M Kiebzak, Garth A Beinart, Karen Perser, et al.
The Journal of Antimicrobial Chemotherapy
|
May 8, 2000
Streptococcus pneumoniae in the USA: in vitro susceptibility and pharmacodynamic analysis
E O Mason, L B Lamberth, N L Kershaw, et al.
Antimicrobial Agents and Chemotherapy
|
September 15, 2001
Pharmacodynamics of fluoroquinolones against Streptococcus pneumoniae in patients with community-acquired respiratory tract infections
P G Ambrose, D M Grasela, T H Grasela, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 23, 2007
Back to the future: using aminoglycosides again and how to dose them optimally
George L Drusano, Paul G Ambrose, Sujata M Bhavnani, et al.
Page
of 25
Search research articles
Search
Showing results (111-120 of 250) with videos related to
Sort By:
Page
of 25
Antimicrobial Agents and Chemotherapy
|
January 24, 2019
APX001 Pharmacokinetic/Pharmacodynamic Target Determination against <i>Aspergillus fumigatus</i> in an <i>In Vivo</i> Model of Invasive Pulmonary Aspergillosis
Miao Zhao, Alexander J Lepak, Karen Marchillo, et al.
Chemotherapy
|
April 18, 2001
Pharmacokinetics of high-dose meropenem in adult cystic fibrosis patients
K Q Bui, P G Ambrose, D P Nicolau, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 21, 2024
Piperacillin/Tazobactam Susceptibility Test Interpretive Criteria for Enterobacterales: Recommendations From the United States Committee on Antimicrobial Susceptibility Testing
Thomas P Lodise, Sujata M Bhavnani, Paul G Ambrose, et al.
The Journal of Infectious Diseases
|
December 28, 2006
Isoniazid's bactericidal activity ceases because of the emergence of resistance, not depletion of Mycobacterium tuberculosis in the log phase of growth
Tawanda Gumbo, Arnold Louie, Weiguo Liu, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society
|
May 17, 2022
An objective assessment for bone drilling: A pilot study on vertical drilling
Aman Nigam, Ronak R Mohanty, James F Kellam, et al.
Diagnostic Microbiology and Infectious Disease
|
June 28, 2008
Pharmacokinetics-pharmacodynamics of quinolones against Streptococcus pneumoniae in patients with community-acquired pneumonia
Sujata M Bhavnani, Alan Forrest, Jeffrey P Hammel, et al.
Archives of Internal Medicine
|
October 24, 2002
Undertreatment of osteoporosis in men with hip fracture
Gary M Kiebzak, Garth A Beinart, Karen Perser, et al.
The Journal of Antimicrobial Chemotherapy
|
May 8, 2000
Streptococcus pneumoniae in the USA: in vitro susceptibility and pharmacodynamic analysis
E O Mason, L B Lamberth, N L Kershaw, et al.
Antimicrobial Agents and Chemotherapy
|
September 15, 2001
Pharmacodynamics of fluoroquinolones against Streptococcus pneumoniae in patients with community-acquired respiratory tract infections
P G Ambrose, D M Grasela, T H Grasela, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 23, 2007
Back to the future: using aminoglycosides again and how to dose them optimally
George L Drusano, Paul G Ambrose, Sujata M Bhavnani, et al.
Page
of 25